# ENSTILAR

NDC: 50222-302
Generic name: calcipotriene and betamethasone dipropionate
Labeler / Manufacturer: LEO Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: AEROSOL, FOAM
Routes: TOPICAL
Marketing started: 20151016

FDA application: NDA207589

## Active ingredients

- BETAMETHASONE DIPROPIONATE: .5 mg/g
- CALCIPOTRIENE MONOHYDRATE: 50 ug/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50222-302"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50222-302
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1193df2-d53f-4342-bd9d-d9cba7c89709